Newsbenzinga
Reported Earlier, MoonLake Immunotherapeutics Prices Upsized $200M Public Offering Of 9M Class A Ordinary Shares At $20.00 Per Share
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…